Is HMGB1 an osteocyte alarmin?

Journal of Cellular Biochemistry

Volumn 103, Issue 6, 2008, Pages 1671-1680

  Bidwell, Joseph P ^a   Yang, Jieping ^a   Robling, Alexander G ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Chemotaxis; Glucocorticoid induced osteoporosis; Inflammation; Necrosis; Osteoimmunology

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ALARMIN; APOPTOSIS; BONE MARROW CELL; CELL CULTURE; CELL DEATH; CHEMOTAXIS; IMMUNE RESPONSE; IMMUNE SYSTEM; INNATE IMMUNITY; MOLECULE; OSTEOCYTE; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; STROMA CELL; TISSUE INJURY; TISSUE REPAIR; VITAL STATISTICS;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; BONE REMODELING; BONE RESORPTION; CELLS, CULTURED; CHEMOTAXIS; CYTOKINES; HMGB1 PROTEIN; HUMANS; IMMUNITY, NATURAL; MICE; OSTEOBLASTS; OSTEOCLASTS; OSTEOCYTES;

EID: 41849110978     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21572     Document Type: Review

References (56)

1. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, Tracey KJ. 2000. High mobility group 1 protein (HMG-1) stimulates pro-inflammatory cytokine synthesis in human monocytes. J Exp Med 192:565-570.
2. Baud'huin M, Lamoureux F, Duplomb L, Redini F, Heymann D. 2007. RANKL, RANK, osteoprotegerin: Key partners of osteoimmunology and vascular diseases. Cell Mol Life Sci 64:2334-2350.
3. Bell CW, Jiang W, Reich CF III, Pisetsky DS. 2006. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 291:C1318-C1325.
4. Bianchi ME. 2007. DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 81:1-5.
5. Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, Rubartelli A, Agresti A, Bianchi ME. 2003. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 22:5551-5560.
6. Bonewald LF. 2007. Osteocyte messages from a bony tomb. Cell Metab 5:410-411.
7. Charatcharoenwitthaya N, Khosla S, Atkinson EJ, McCready LK, Riggs BL. 2007. Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res 22:724-729.
8. Charoonpatrapong K, Shah R, Robling AG, Alvarez M, Clapp DW, Chen S, Kopp RP, Pavalko FM, Yu J, Bidwell JP. 2006. HMGB1 expression and release by bone cells. J Cell Physiol 207:480-490.
9. Chou DK, Zhang J, Smith FI, McCaffery P, Jungalwala FB. 2004. Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration. J Neurochem 90:1389-1401.
10. Degryse B, Bonaldi T, Scaffidi P, Muller S, Resnati M, Sanvito F, Arrigoni G, Bianchi ME. 2001. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 152:1197-1206.
11. Ding KH, Wang ZZ, Hamrick MW, Deng ZB, Zhou L, Kang B, Yan SL, She JX, Stern DM, Isales CM, Mi QS. 2006. Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss. Biochem Biophys Res Commun 340:1091-1097.
12. Dumitriu IE, Baruah P, Valentinis B, Voll RE, Herrmann M, Nawroth PP, Arnold B, Bianchi ME, Manfredi AA, Rovere-Querini P. 2005. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 174(12):7506-7515.
13. Dumitriu IE, Bianchi ME, Bacci M, Manfredi AA, Rovere-Querini P. 2007. The secretion of HMGB1 is required for the migration of maturing dendritic cells. J Leukoc Biol 81:84-91.
14. El Mezayen R, El Gazzar M, Seeds MC, McCall CE, Dreskin SC, Nicolls MR. 2007. Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. Immunol Lett 111:36-44.
15. Ellerman JE, Brown CK, de Vera M, Zeh HJ, Billiar T, Rubartelli A, Lotze MT. 2007. Masquerader: High mobility group box-1 and cancer. Clin Cancer Res 13:2836-2848.
16. Fan J, Li Y, Levy RM, Fan JJ, Hackam DJ, Vodovotz Y, Yang H, Tracey KJ, Billiar TR, Wilson MA. 2007. Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: Role of HMGB1-TLR4 signaling. J Immunol 178:6573-6580.
17. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, Suffredini AF. 2003. Inflammation-promoting activity of HMGB1 on human microvascular endothelialcells. Blood 101:2652-2660.
18. Herold K, Moser B, Chen Y, Zeng S, Yan SF, Ramasamy R, Emond J, Clynes R, Schmidt AM. 2007. Receptor for advanced glycation end products (RAGE) in a dash to the rescue: Inflammatory signals gone awry in the primal response to stress. J Leukoc Biol 82:204-212.
19. Hofmann MA, Drury S, Hudson BI, Gleason MR, Qu W, Lu Y, Lalla E, Chitnis S, Monteiro J, Stickland MH, Bucciarelli LG, Moser B, Moxley G, Itescu S, Grant PJ, Gregersen PK, Stern DM, Schmidt AM. 2002. RAGE and arthritis: The G82S polymorphism amplifies the inflammatory response. Genes Immun 3:123-135.
20. Inoue K, Kawahara K, Biswas KK, Ando K, Mitsudo K, Nobuyoshi M, Maruyama I. 2007. HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques. Cardiovasc Pathol 16:136-143.
21. Ito I, Fukazawa J, Yoshida M. 2007. Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils. J Biol Chem 282:16336-16344.
22. Jiang W, Bell CW, Pisetsky DS. 2007. The relationship between apoptosis and high-mobility group protein 1 release from murine macrophages stimulated with lipopolysaccharide or polyinosinic-polycytidylic acid. J Immunol 178:6495-6503.
23. Klesney-Tait J, Turnbull IR, Colonna M. 2006. The TREM receptor family and signal integration. Nat Immunol 7:1266-1273.
24. Kogianni G, Noble BS. 2007. The biology of osteocytes. Curr Osteoporos Rep 5:81-86.
25. Kokkola R, Li J, Sundberg E, Aveberger AC, Palmblad K, Yang H, Tracey KJ, Andersson U, Harris HE. 2003. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum 48:2052-2058.
26. Lin L. 2006. RAGE on the toll road? Cell Mol Immunol 3:351-358.
27. Lotze MT, Tracey KJ. 2005. High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat Rev Immunol 5:331-342.
28. Mitsouras K, Wong B, Arayata C, Johnson RC, Carey M. 2002. The DNA architectural protein HMGB1 displays two distinct modes of action that promote enhanceosome assembly. Mol Cell Biol 22:4390-4401.
29. Noble B. 2003. Bone microdamage and cell apoptosis. Eur Cell Mater 6:46-55.
30. Noble BS, Stevens H, Loveridge N, Reeve J. 1997. Identification of apoptotic changes in osteocytes in normal and pathological human bone. Bone 20:273-282.
31. O'Brien CA, Jia D, Plotkin LI, Bellido T, Powers CC, Stewart SA, Manolagas SC, Weinstein RS. 2004. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145:1835-1841.
32. Orlova W, Choi EY, Xie C, Chavakis E, Bierhaus A, Ihanus E, Ballantyne CM, Gahmberg CG, Bianchi ME, Nawroth PP, Chavakis T. 2007. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J 26:1129-1139.
33. Park JS, Arcaroli J, Yum HK, Yang H, Wang H, Yang KY, Choe KH, Strassheim D, Pitts TM, Tracey KJ, Abraham E. 2003. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 284:C870-C879.
34. Pedrazzi M, Raiteri L, Bonanno G, Patrone M, Ledda S, Passalacqua M, Milanese M, Melloni E, Raiteri M, Pontremoli S, Sparatore B. 2006. Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein. J Neurochem 99:827-838.
35. Pennisi P, Trombetti A, Rizzoli R. 2006. Glucocorticoid-induced osteoporosis and its treatment. Clin Orthop Relat Res 443:39-47.
36. Popovic PJ, DeMarco R, Lotze MT, Winikoff SE, Bartlett DL, Krieg AM, Guo ZS, Brown CK, Tracey KJ, Zeh HJ III. 2006. High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists. J Immunol 177:8701-8707.
37. Porto A, Palumbo R, Pieroni M, Aprigliano G, Chiesa R, Sanvito F, Maseri A, Bianchi ME. 2006. Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein. FASEB J 20:E1955-E1963.
38. Romas E, Gillespie MT. 2006. Inflammation-induced bone loss: Can it be prevented? Rheum Dis Clin North Am 2006. 32:759-773.
39. Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B, Catalnotti F, Giazzon M, Dumitiriu IE, Muller S, Iannacone M, Traversari C, Bianchi M, Manfredi AA. 2004. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 5:825-830.
40. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H. 2006. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203:2673-2682.
41. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C, Hofmann MA, Kislinger T, Ingram M, Lu A, Tanaka H, Hori O, Ogawa S, Stern DM, Schmidt AM. 2000. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405:354-360.
42. Takata K, Kitamura Y, Kakimura J, Shibagaki K, Tsuchiya D, Taniguchi T, Smith MA, Perry G, Shimohama S. 2003. Role of high mobility group protein-1 (HMG1) in amyloid-beta homeostasis. Biochem Biophys Res Commun 301:699-703.
43. Takata K, Kitamura Y, Tsuchiya D, Kawasaki T, Taniguchi T, Shimohama S. 2004. High mobility group box protein-1 inhibits microglial Abeta clearance and enhances Abeta neurotoxicity. J Neurosci Res 78:880-891.
44. Takayanagi H. 2007. Osteoimmunology: Shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7:292-304.
45. Taniguchi N, Yoshida K, Ito T, Tsuda M, Mishima Y, Furumatsu T, Ronfani L, Abeyama K, Kawahara K, Komiya S, Maruyama I, Lotz M, Bianchi ME, Asahara H. 2007. Stage-specific secretion of HMGB1 in cartilage regulates endochondral ossification. Mol Cell Biol 27:5650-5663.
46. Theill LE, Boyle WJ, Penninger JM. 2002. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol 20:795-823.
47. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, Parroche P, Drabic S, Golenbock D, Sirois C, Hua J, An LL, Audoly L, La Rosa G, Bierhaus A, Naworth P, Marshak-Rothstein A, Crow MK, Fitzgerald KA, Latz E, Kiener PA, Coyle AJ. 2007. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8:487-496.
48. Ueda T, Chou H, Kawase T, Shirakawa H, Yoshida M. 2004. Acidic C-tail of HMGB1 is required for its target binding to nucleosome linker DNA and transcription stimulation. Biochemistry 43:9901-9908.
49. van Beijnum JR, Dings RP, van der Linden E, Zwaans BM, Ramaekers FC, Mayo KH, Griffioen AW. 2006. Gene expression of tumor angiogenesis dissected: Specific targeting of colon cancer angiogenic vasculature. Blood 108:2339-2348.
50. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251.
51. Yamamoto S, Mogi M, Kinpara K, Ishihara Y, Ueda N, Amano K, Nishihara T, Noguchi T, Togari A. 1999. Anti-proliferative capsular-like polysaccharide antigen from Actinobacillus actinomycetemcomitans induces apoptotic cell death in mouse osteoblastic MC3T3-E1 cells. J Dent Res 78:1230-1237.
52. Yang J, Shah R, Robling AG, Templeton E, Yang H, Tracey KJ, Bidwell JP. 2007. HMGB1 is a bone-active cytokine J Cell Physiol; DOI: 10.1002/jcp.21268.
53. Yeh HS, Berenson JR. 2006. Myeloma bone disease and treatment options. Eur J Cancer 42:1554-1563.
54. Youn JH, Shin JS. 2006. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J Immunol 177:7889-7897.
55. Yu M, Wang H, Ding A, Golenbock DT, Latz E, Czura CJ, Fenton MJ, Tracey KJ, Yang H. 2006. HMGB1 signals through toll-like receptor (TLR) 4 and T LR2. Shock 26:174-179.
56. Zhou Z, Immel D, Xi CX, Bierhaus A, Feng X, Mei L, Nawroth P, Stern DM, Xiong WC. 2006. Regulation of osteoclast function and bone mass by RAGE. J Exp Med 203:1067-1080.